SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-105624
Filing Date
2023-10-02
Accepted
2023-10-02 08:00:18
Documents
13
Period of Report
2023-09-29
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2327307d1_8k.htm   iXBRL 8-K 23753
2 EXHIBIT 3.1 tm2327307d1_ex3-1.htm EX-3.1 24086
  Complete submission text file 0001104659-23-105624.txt   231000

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ptpi-20230929.xsd EX-101.SCH 3027
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptpi-20230929_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptpi-20230929_pre.xml EX-101.PRE 22367
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2327307d1_8k_htm.xml XML 3529
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39752 | Film No.: 231297831
SIC: 2834 Pharmaceutical Preparations